Intrauterine Contraceptive Devices Market is expected to reach US$ 6.92 Billion by 2033 | Bayer, Pregna, Sebela Pharmaceutical, AbbVie, Eurogine, SMB Corporation

Intrauterine Contraceptive Devices (IUD) Market reached US$ 4.56 Billion in 2024 and is expected to reach US$ 6.92 Billion by 2033, growing at a CAGR of 4.8% during the forecast period 2025-2033.

Intrauterine Contraceptive Devices Market is gaining momentum across key geographies, driven by digital innovation and changing consumer expectations. This market report provides in-depth analysis, keyword-optimized forecasts, and actionable insights for businesses aiming to refine go-to-market strategies and strengthen brand positioning.

Get your exclusive sample report today: (corporate email gets priority access): https://datamintelligence.com/download-sample/intrauterine-contraceptive-devices-market?sg

Intrauterine Contraceptive Devices Market Landscape Analysis:

An intrauterine device (IUD) is a small, T-shaped plastic device designed for birth control. It is placed inside the uterus, where it works to prevent pregnancy by stopping sperm from fertilizing an egg and hindering a fertilized egg from implanting in the uterine lining. In addition to its contraceptive role, research is ongoing into the potential use of IUDs in the prevention and treatment of endometrial cancer and other medical conditions.

IUDs are among the most reliable contraceptive options available, with effectiveness comparable to permanent methods like sterilization. They offer several advantages, including high success rates, minimal maintenance, reversibility, and overall user satisfaction especially when considering their long-term cost-effectiveness and convenience. This overview will explore the indications, contraindications, benefits, and potential risks involved in IUD insertion and removal. It will also highlight the importance of a collaborative healthcare approach to ensure optimal care for individuals choosing this method of contraception.

Intrauterine Contraceptive Devices Market: Shifting Industry Trends and Market Potential

Rising Adoption of IUDs Fuels Growth in the Intrauterine Contraceptive Devices Market

The global intrauterine contraceptive devices (IUDs) market is experiencing steady growth, driven by several key factors. Increasing public awareness about contraceptive options plays a significant role, alongside advances in technology and supportive government policies aimed at promoting family planning.

According to the United Nations, approximately 161 million individuals worldwide use IUDs, making them one of the most widely adopted contraceptive methods. In the United States, data from the CDC (as of December 2023) shows that 20.4% of women with sexual experience have used an IUD at some point. The popularity of this method has grown significantly from just 2.4% of contraceptive users aged 15 to 44 in 2002 to 14% in 2016. Women aged 25 to 29 represent the demographic with the highest IUD usage at 19%, while the lowest rates around 5-6% are found among those aged 15 to 19 and 45 to 49.

Regional disparities in IUD usage also highlight its variable adoption across the globe. A 2023 article from the National Institutes of Health (NIH) notes that usage rates in Eastern and Southeastern Asia and Northern Africa are around 18%. In countries like Tunisia and Egypt, the figures are much higher-27.8% and 36.1%, respectively. In Ethiopia, although the overall use of modern contraceptives among married women nearly tripled between 2005 and 2019 (from 14% to 41%), IUDs remain a minor component of the contraceptive mix. Usage ranges from 5.2% in Addis Ababa to just 0.4% in the Gambella region, with virtually no uptake in the Somali region.

These trends reflect both the growing acceptance of IUDs as a reliable long-term contraceptive solution and the need for targeted initiatives to boost adoption in underrepresented regions.

Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/intrauterine-contraceptive-devices-market?sg

Strategic Players Driving the Intrauterine Contraceptive Devices Market Forward: Teva Pharmaceuticals, Bayer, Pregna, Sebela Pharmaceuticals, CooperSurgical, Inc., AbbVie, Eurogine, and SMB Corporation.

Intrauterine Contraceptive Devices Market Recent Industry News:

In February 2025, Sebela Women's Health Inc., a part of Sebela Pharmaceuticals, announced that the U.S. Food and Drug Administration (FDA) granted approval of MIUDELLA (copper intrauterine system) for the prevention of pregnancy in females of reproductive potential for up to three years. MIUDELLA is a next-generation, hormone-free, low-dose copper intrauterine device or IUD, the first to be approved by the FDA in the United States in over 40 years.

In July 2024, 3Daughters, a clinical development company dedicated to advancing women's healthcare, announced the successful completion of an oversubscribed seed financing round, raising $4.7 million. This round saw participation from existing investors including Thairm Bio, Argosy Foundation, Wexford Science and Technology, UMass Amherst, and new undisclosed investors.

Stay informed with the latest industry insights-start your subscription now: https://www.datamintelligence.com/reports-subscription?sg

Segment Covered in the Intrauterine Contraceptive Devices Market:

By Type (Hormonal IUD, Copper IUD)

By End-User (Hospitals, Gynecology Clinics, Community Healthcare Centers, Others)

By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Regional Analysis for Intrauterine Contraceptive Devices Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Most Frequently Asked Questions in the Intrauterine Contraceptive Devices Market Research Industry:

✒ What are the primary drivers fueling growth in the Intrauterine Contraceptive Devices Market today?
✒ Which companies are currently leading innovation and market share in the Intrauterine Contraceptive Devices Market?
✒ In what ways is the current regulatory environment influencing the Intrauterine Contraceptive Devices Market's trajectory?
✒ Which geographic regions are forecasted to experience the strongest growth in the Intrauterine Contraceptive Devices Market and why?
✒ What are the key barriers or challenges that could limit the growth of the Intrauterine Contraceptive Devices Market?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.